FI893170L - Menetelmä uusien terapeuttisesti käyttökelpoisten 1,2,3-triatsolo/4,5-f/kinoksaliinijohdannaisten valmistamiseksi - Google Patents
Menetelmä uusien terapeuttisesti käyttökelpoisten 1,2,3-triatsolo/4,5-f/kinoksaliinijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI893170L FI893170L FI893170A FI893170A FI893170L FI 893170 L FI893170 L FI 893170L FI 893170 A FI893170 A FI 893170A FI 893170 A FI893170 A FI 893170A FI 893170 L FI893170 L FI 893170L
- Authority
- FI
- Finland
- Prior art keywords
- triazolo
- therapeutically useful
- quinoxaline derivatives
- preparing novel
- novel therapeutically
- Prior art date
Links
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
- C07D517/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Luminescent Compositions (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI931894A FI93839C (fi) | 1988-06-28 | 1993-04-27 | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3-dihydroksi-pyratsino/2,3-f/kinoksaliini- ja pyratsino/2,3-g//1,5/bentsodiatsepiinijohdannaisten valmistamiseksi |
| FI931893A FI93840C (fi) | 1988-06-28 | 1993-04-27 | Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1,2,5-oksa-, tia- ja seleenidiatsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi |
| FI931891A FI93838C (fi) | 1988-06-28 | 1993-04-27 | Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1H-imidatso- ja pyratsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi |
| FI931892A FI93841C (fi) | 1988-06-28 | 1993-04-27 | Menetelmä uusien terapeuttisesti käyttökelpoisten tiatsolo/5,4-f/- ja tieno/3,2-f/kinoksaliinijohdannaisten valmistamiseksi |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK356788 | 1988-06-28 | ||
| DK356788A DK160941C (da) | 1988-06-28 | 1988-06-28 | Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI893170A0 FI893170A0 (fi) | 1989-06-28 |
| FI893170L true FI893170L (fi) | 1989-12-29 |
| FI91259B FI91259B (fi) | 1994-02-28 |
| FI91259C FI91259C (fi) | 1994-06-10 |
Family
ID=8124358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI893170A FI91259C (fi) | 1988-06-28 | 1989-06-28 | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,2,3-triatsolo/4,5-f/kinoksaliinijohdannaisten valmistamiseksi |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US4977155A (fi) |
| EP (1) | EP0348872B1 (fi) |
| JP (1) | JPH0248578A (fi) |
| KR (1) | KR910000735A (fi) |
| AT (1) | ATE95181T1 (fi) |
| AU (1) | AU619863B2 (fi) |
| CA (1) | CA1326670C (fi) |
| DE (1) | DE68909513T2 (fi) |
| DK (1) | DK160941C (fi) |
| ES (1) | ES2059636T3 (fi) |
| FI (1) | FI91259C (fi) |
| IE (1) | IE64289B1 (fi) |
| IL (1) | IL90733A (fi) |
| NO (1) | NO169390C (fi) |
| NZ (1) | NZ229730A (fi) |
| PH (1) | PH27565A (fi) |
| PT (1) | PT91010B (fi) |
| ZA (1) | ZA894903B (fi) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153195A (en) * | 1988-12-22 | 1992-10-06 | Novo Nordisk A/S | Quinoxaline compounds and their preparation and use |
| DK716188D0 (da) * | 1988-12-22 | 1988-12-22 | Ferrosan As | Quinoxalinforbindelser, deres fremstilling og anvendelse |
| PT99864B (pt) | 1990-12-21 | 1999-06-30 | Schering Ag | Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato |
| US5196421A (en) * | 1991-06-05 | 1993-03-23 | Eli Lilly And Company | Excitatory amino acid receptor antagonists in methods for the use thereof |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
| DK162491D0 (da) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne |
| ES2313714T3 (es) * | 1992-06-22 | 2009-03-01 | The Regents Of The University Of California | Antagonistas de receptores de glicina y uso de los mismos. |
| AU680632B2 (en) | 1992-10-13 | 1997-08-07 | Neurosearch A/S | Quinoxalinedione derivatives as EAA antagonists |
| DE4310523A1 (de) * | 1993-03-31 | 1994-10-06 | Basf Ag | Imidazolo-chinoxalinone zur Behandlung zentralnervöser Erkrankungen |
| US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| US5576323A (en) * | 1993-12-03 | 1996-11-19 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| AU688459B2 (en) * | 1994-04-08 | 1998-03-12 | Shionogi & Co., Ltd. | Oxopyridinylquinoxaline derivative |
| US5476851A (en) * | 1994-09-08 | 1995-12-19 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase |
| US5719153A (en) * | 1995-08-15 | 1998-02-17 | American Home Products Corporation | 5H,8H-2-oxa-1,3,5,8-tetraaza-cyclopenta b!-naphthalene-6,7-diones |
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| KR20000036227A (ko) | 1996-09-27 | 2000-06-26 | 토마스 씨. 서 | 날라다아제조성물, 글루탐산염 이상 치료법 및 동물내의 뉴우런활성법 |
| WO1998032439A1 (en) * | 1997-01-23 | 1998-07-30 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| US6288075B1 (en) | 1998-02-26 | 2001-09-11 | Rhone-Poulenc Rorer S.A. | Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same |
| FR2760237B1 (fr) * | 1997-02-28 | 1999-04-16 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
| FR2766487B1 (fr) * | 1997-07-28 | 1999-08-27 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
| US6262044B1 (en) | 1998-03-12 | 2001-07-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPASES) |
| WO1999046267A1 (en) * | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| JP2009286778A (ja) * | 2008-04-30 | 2009-12-10 | Sumitomo Chemical Co Ltd | ｔｅｒｔ−ブチル３−アミノピペリジン−１−カルボキシレートの製造方法およびその中間体 |
| EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
| CN113549087B (zh) * | 2020-04-26 | 2025-09-12 | 北京鼎材科技有限公司 | 一种化合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1246578A (en) * | 1982-03-29 | 1988-12-13 | John H. Musser | 2-oxo-1,3-oxazolo[4,5]quinolines useful as anti-allergy agents |
| DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
-
1988
- 1988-06-28 DK DK356788A patent/DK160941C/da not_active IP Right Cessation
-
1989
- 1989-06-21 IE IE200889A patent/IE64289B1/en not_active IP Right Cessation
- 1989-06-22 US US07/369,762 patent/US4977155A/en not_active Expired - Fee Related
- 1989-06-23 CA CA000603702A patent/CA1326670C/en not_active Expired - Fee Related
- 1989-06-23 IL IL9073389A patent/IL90733A/en not_active IP Right Cessation
- 1989-06-26 DE DE89111622T patent/DE68909513T2/de not_active Expired - Fee Related
- 1989-06-26 ES ES89111622T patent/ES2059636T3/es not_active Expired - Lifetime
- 1989-06-26 EP EP89111622A patent/EP0348872B1/en not_active Expired - Lifetime
- 1989-06-26 AT AT89111622T patent/ATE95181T1/de active
- 1989-06-27 NO NO892680A patent/NO169390C/no unknown
- 1989-06-27 NZ NZ229730A patent/NZ229730A/en unknown
- 1989-06-27 AU AU37077/89A patent/AU619863B2/en not_active Ceased
- 1989-06-28 PH PH38872A patent/PH27565A/en unknown
- 1989-06-28 JP JP1164091A patent/JPH0248578A/ja active Pending
- 1989-06-28 FI FI893170A patent/FI91259C/fi not_active IP Right Cessation
- 1989-06-28 PT PT91010A patent/PT91010B/pt not_active IP Right Cessation
- 1989-06-28 KR KR1019890008933A patent/KR910000735A/ko not_active Ceased
- 1989-06-28 ZA ZA894903A patent/ZA894903B/xx unknown
-
1990
- 1990-08-20 US US07/570,019 patent/US5075306A/en not_active Expired - Fee Related
- 1990-08-22 US US07/570,903 patent/US5057516A/en not_active Expired - Fee Related
- 1990-08-22 US US07/570,819 patent/US5109001A/en not_active Expired - Fee Related
- 1990-08-23 US US07/572,172 patent/US5079250A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0248578A (ja) | 1990-02-19 |
| AU3707789A (en) | 1990-01-04 |
| ZA894903B (en) | 1990-03-28 |
| US5075306A (en) | 1991-12-24 |
| IL90733A (en) | 1994-02-27 |
| AU619863B2 (en) | 1992-02-06 |
| ATE95181T1 (de) | 1993-10-15 |
| FI893170A0 (fi) | 1989-06-28 |
| DK356788D0 (da) | 1988-06-28 |
| US5057516A (en) | 1991-10-15 |
| NO892680L (no) | 1989-12-29 |
| DK356788A (da) | 1990-03-21 |
| IE64289B1 (en) | 1995-07-26 |
| PT91010A (pt) | 1989-12-29 |
| NO169390C (no) | 1992-06-17 |
| DE68909513T2 (de) | 1994-01-20 |
| US4977155A (en) | 1990-12-11 |
| IE892008L (en) | 1989-12-28 |
| NO169390B (no) | 1992-03-09 |
| PH27565A (en) | 1993-08-18 |
| NO892680D0 (no) | 1989-06-27 |
| EP0348872A1 (en) | 1990-01-03 |
| NZ229730A (en) | 1991-07-26 |
| DE68909513D1 (de) | 1993-11-04 |
| PT91010B (pt) | 1995-01-31 |
| CA1326670C (en) | 1994-02-01 |
| DK160941B (da) | 1991-05-06 |
| IL90733A0 (en) | 1990-01-18 |
| KR910000735A (ko) | 1991-01-30 |
| US5109001A (en) | 1992-04-28 |
| DK160941C (da) | 1991-10-21 |
| ES2059636T3 (es) | 1994-11-16 |
| FI91259C (fi) | 1994-06-10 |
| FI91259B (fi) | 1994-02-28 |
| US5079250A (en) | 1992-01-07 |
| EP0348872B1 (en) | 1993-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI893170L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,2,3-triatsolo/4,5-f/kinoksaliinijohdannaisten valmistamiseksi | |
| FI890282L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| FI906438L (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi | |
| FI880816A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi | |
| FI871041A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3,5-disubstituoitujen pyrokatekolijohdannaisten valmistamiseksi | |
| FI885409A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsiiniamiinijohdannaisten valmistamiseksi | |
| FI893433A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi | |
| FI853999A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi. | |
| FI873350A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI890245A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-disubstituoitujen piperidinyylijohdannaisten valmistamiseksi | |
| FI883603A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI884627A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten dideoksisytidiinijohdannaisten valmistamiseksi | |
| FI880467A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
| FI893326A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,3-disubstituoitujen piperidiinijohdannaisten valmistamiseksi | |
| FI881892A7 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi | |
| FI881525A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi | |
| FI884660L (fi) | Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi | |
| FI893003L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
| FI885560A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
| FI874789L (fi) | Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja | |
| KR850004570A (ko) | 2,2-디플루오로프로피온산 유도체의 제조방법 | |
| FI98459B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi | |
| FI893345A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsinonijohdannaisten valmistamiseksi | |
| FI892946A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi | |
| FI893682L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: NOVO NORDISK A/S |